Forte Biosciences FBRX
NASDAQ FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Prepaid Assets (2016 - 2026)

Forte Biosciences (FBRX) posted quarterly Prepaid Assets of $6.9 million for Q1 2026, up 428.96% year-over-year from $1.3 million in Q1 2025, and up 89.62% quarter-over-quarter from $3.6 million in Q4 2025.

Analysis

Forte Biosciences (FBRX) Prepaid Assets (2016 - 2026) Analysis & Trends

Forte Biosciences (FBRX) has reported Prepaid Assets for 11 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 428.96% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (up 428.96% YoY), while the FY2025 annual figure was $3.6 million, up 1169.93% from the prior year.
  • Prepaid Assets climbed to $6.9 million in Q1 2026 per FBRX's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $6.9 million in Q1 2026 and bottomed at $70000.0 in Q4 2022.
  • Historically, Prepaid Assets has averaged $935235.3 across 5 years, with a median of $286000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Prepaid Assets plunged 86.64% — and 2025, when it soared 1169.93%.
  • Forte Biosciences' Prepaid Assets stood at $70000.0 in 2022, then jumped by 354.29% to $318000.0 in 2023, then decreased by 10.06% to $286000.0 in 2024, then jumped by 1169.93% to $3.6 million in 2025, then soared by 89.62% to $6.9 million in 2026.
  • Business Quant data shows FBRX's Prepaid Assets at $6.9 million in Q1 2026, $3.6 million in Q4 2025, and $471000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Forte Biosciences 1.58 Bn 1.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.64 Mn
Mar 31, 2026 6.89 Mn
Dec 31, 2025 3.63 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 1.47 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 2.98 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 1.06 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 917,000.00
Jun 30, 2023 322,000.00
Mar 31, 2023 369,000.00
Dec 31, 2022 411,000.00
Sep 30, 2022 546,000.00
Jun 30, 2022 298,000.00
Mar 31, 2022 376,000.00
Dec 31, 2021 476,000.00
Sep 30, 2021 891,000.00